• 1
    Fondevila C, Busuttil RW, Kupiec-Weglinski JW. Hepatic ischemia/reperfusion injury—a fresh look. Exp Mol Pathol 2003; 74: 8693.
  • 2
    Henrion J. Ischemia/reperfusion injury of the liver: Pathophysiologic hypotheses and potential relevance to human hypoxic hepatitis. Acta Gastroenterol Belg 2000; 63: 336347.
  • 3
    Clavien PA, Harvey PRC, Strasberg SM. Preservation and reperfusion injuries in liver allografts. Transplantation 1992; 53: 957978.
  • 4
    Noack K, Bronk SF, Kato A, Gores GJ. The greater vulnerability of the bile duct cells to reoxygenation injury than anoxia. Implications for the pathogenesis of biliary strictures after liver transplantation. Transplantation 1993; 56: 495500.
  • 5
    Lawson JA, Fisher MA, Simmons GA, Farhood A, Jaeschke H. Parenchymal cell apoptosis as a signal for sinusoidal sequestration and transendothelial migration of neutrophils in murine models of endotoxin and Fas-antibody-induced liver injury. Hepatology 1998; 28: 761767.
  • 6
    Ando K, Moriyama T, Guidotti LG et al. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant heptitis. J Exp Med 1993; 178: 15411554.
  • 7
    Faouzi S, Burckhardt BE, Hanson JC et al. Anti-Fas induces hepatic chemokines and promotes inflammation by an NF-kappaB-independent, caspase-3-dependent pathway. J Biol Chem 2001; 276: 4907749082.
  • 8
    Kohli V, Gao W, Camargo CA, Clavien PA. Calpain is a mediator of preservation-reperfusion injury in rat liver transplantation. Proc Natl Acad USA 1997; 94: 93549359.
  • 9
    Caldwell-Kenkel JC, Currin RT, Tanaka Y, Thurman RG, Lemasters JJ. Kupffer cell activation and endothelial cell damage after storage of rat livers: Effects of reperfusion. Hepatology 1991; 13: 8395.
  • 10
    Jaeschke H, Farhood A. Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver in vivo. Am J Physiol 1991; 260: G355G363.
  • 11
    Jaeschke H. Kupffer cell-induced oxidant stress during hepatic ischemia-reperfusion: Does the controversy continue? Hepatology 1999; 30: 15271528.
  • 12
    Kumamoto Y, Suematsu M, Shimazu M et al. Kupffer cell-independent acute hepatocellular oxidative stress and decreased bile formation in post cold-ischemic rat liver. Hepatology 1999; 30: 14541463.
  • 13
    Jaeschke H, Farhood A, Bautista AP, Spolarics Z, Spitzer JJ. Complement activates Kupffer cells and neutrophils during reperfusion after hepatic ischemia. Am J Physiol 1993; 264: G801G809.
  • 14
    Jaeschke H, Farhood A, Smith CW. Neutrophils contribute to ischemia/reperfusion in rat liver in vivo. FASEB J 1990; 4: 33553359.
  • 15
    Carles J, Fawaz R, Hamoudi NE et al. Preservation of human liver grafts in UW solution. Ultrastructural evidence for endothelial and Kuppfer cell activation during cold ischemia and after ischemia-reperfusion. Liver 1994; 14: 5056.
  • 16
    Kiuchi T, Oldhafer KJ, Schlitt HJ et al. Background and prognostic implications of perireperfusion tissue injuries in human liver transplantation: A panel histochemical study. Transplantation 1998; 66: 737747.
  • 17
    Kawamura E, Yamanaka N, Okamoto E et al. Response of plasma and tissue endothelin-1 to liver ischemia and its implication in ischemia-reperfusion injury. Hepatology 1995; 21: 11381143.
  • 18
    Shiraishi M, Hiroyasu S, Nagahama M et al. Role of exogenous L-arginine in hepatic reperfusion injury. J Surg Res 1997; 69: 429434.
  • 19
    Suzuki S, Toledo-Pereyra LH. Interleukin 1 and tumour necrosis factor production as the initial stimulants of liver ischemia and reperfusion injury. J Surg Res 1994; 57: 253258.
  • 20
    Clavien PA, Camargo CA Jr., Gorczynski R et al. Acute reactant cytokines and neutrophil adhesion after warm ischemia in cirrhotic and noncirrhotic human livers. Hepatology 1996; 23: 14561463.
  • 21
    Borghi-Scoazec G, Scoazec JY, Durand F et al. Apoptosis after ischemia-reperfusion in human liver allografts. Liver Transplant Surg 1997; 3: 407415.
  • 22
    Hosack DA, Dennis G Jr, Sherman BT, Lane HC, Lempicki RA. Identifying biological themes within lists of genes with EASE. Genome Biol 2003; 4: R70. Epub 2003 Sep 11.
  • 23
    Cattral MS, Molinari M, Vollmer CM Jr. et al. Living-donor right hepatectomy with or without inclusion of middle hepatic vein: Comparison of morbidity and outcome in 56 patients. Am J Transplant 2004; 4: 751757.
  • 24
    Chen L, Borozan I, Feld J et al. Hepatic gene expression profiling discriminates responders and non-responders in treatment of chronic hepatitis C viral infection. Gastroenterology 2005; 128: 14371444.
  • 25
    Nathens AB, Marshall JC, Watson RWG, Dackiw APB, Rotstein OD. Diethylmaleate attenuates endotoxin-induced lung injury. Surgery 1996; 120: 360366.
  • 26
    Jocelyn PC. Spectrophotometric assay of thiols. Methods Enzymology 1987; 143: 4467.
  • 27
    Chen L, Goryachev A, Sun J et al. Altered expression of genes involved in hepatic morphogenesis and fibrogenesis are identified by cDNA microarray analysis in biliary atresia. Hepatology 2003; 38: 567576.
  • 28
    Becker RA, Chambers JM, Wilks AR. The new S language. Pacific Grove, CA: Wadsworth and Brooks/Cole, 1988.
  • 29
    Cleveland WS. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc 1979; 74: 829836.
  • 30
    Cleveland WS. LOWESS: A program for smoothing scatterplots by robust locally weighted regression. Am Stat 1981; 35: 54.
  • 31
    Dudoit S, Shaffer JP, Boldrick JC. Multiple hypothesis testing in microarray experiments. Stat Sci 18: 71103.
  • 32
    Anderberg MR. Cluster analysis for applications. New York : Academic Press, 1973.
  • 33
    Gordon AD. Classification, 2nd Ed. London : Chapman and Hall CRC, 1999.
  • 34
    Gentleman RC, Carey VJ, Bates DM et al. Bioconductor: Open software development for computational biology and bioinformatics. Genome Biol 2004; 5: R80;
  • 35
    Gene Ontology: Tool for the unification of biology. The Gene Ontology Consortium. Nature Genet 2000; 25: 2529.
  • 36
    Jia SH, Li Y, Parodo J et al. Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest 2004; 113: 13181327.
  • 37
    Rongvaux A, Shea RJ, Mulks MH et al. Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis. Eur J Immunol 2002; 32: 32253234.
  • 38
    Ye SQ, Simon BA, Maloney JP et al. Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury. Am J Respir Crit Care Med 2005; 171: 361370. Epub 2004 Dec 3.
  • 39
    Fukuhara A, Matsuda M, Nishizawa M et al. Visfatin: A protein secreted by visceral fat that mimics the effects of insulin. Science 2005; 307: 426430.
  • 40
    Kaneider NC, Reinisch CM, Dunzendorfer S, Romisch J, Wiedermann CJ. Syndecan-4 mediates antithrombin-induced chemotaxis of human peripheral blood lymphocytes and monocytes. J Cell Sci 2002; 115(Pt 1): 227236.
  • 41
    Kaneider NC, Forster E, Mosheimer B, Sturn DH, Christian J. Wiedermann, Syndecan-4-dependent signaling in the inhibition of endotoxin-induced endothelial adherence of neutrophils by antithrombin. Thromb Haemost 2003; 90: 11501157.
  • 42
    Nardacci R, Lo Iacono O, Ciccosanti F et al. Transglutaminase type II plays a protective role in hepatic injury. Am J Pathol 2003; 162: 12931303.
  • 43
    Szondy Z, Sarang Z, Molnar P et al. Transglutaminase 2−/− mice reveal a phagocytosis-associated crosstalk between macrophages and apoptotic cells. Proc Natl Acad Sci USA 2003; 100: 78127817. Epub 2003 Jun 16.
  • 44
    Wu J, Zern MA. Tissue transglutaminase, a key enzyme involved in liver diseases. Hepatol Res 2004; 29: 18.
  • 45
    Dong H, Toyoda N, Yoneyama H et al. Gene expression profile analysis of the mouse liver during bacteria-induced fulminant hepatitis by a cDNA microarray system. Biochem Biophys Res Commun 2002; 298: 675686.
  • 46
    Syrovets T, Jendrach M, Rohwedder A, Schule A, Simmet T. Plasmin-induced expression of cytokines and tissue factor in human monocytes involves AP-1 and IKKbeta-mediated NF-kappaB activation. Blood 2001; 97: 39413950.
  • 47
    Filomeni G, Rotilio G, Ciriolo MR. Cell signalling and the glutathione redox system. Biochem Pharmacol 2002; 64: 10571064.
  • 48
    Kwon YH, Jovanovic A, Serfas MS, Tyner AL. The Cdk inhibitor p21 is required for necrosis, but it inhibits apoptosis following toxin-induced liver injury. J Biol Chem 2003; 278: 3034830355. Epub 2003 May 20.
  • 49
    Crary GS, Albrecht JH. Expression of cyclin-dependent kinase inhibitor p21 in human liver. Hepatology 1998; 28: 738743.
  • 50
    Xu XP, Li KZ, Dou KF, Liu FQ, Zhang JR. Effect of coenzyme I on apoptosis of liver cell line L02 induced by ischemia-reperfusion injury. Di Yi Jun Yi Da Xue Xue Bao 2002; 22: 512514.
  • 51
    Zhai Y, Shen XD, O'Connell R et al. Cutting Edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J Immunol 2004; 173: 71157119.